Cimas Medical Aid Faces Probe Over Alleged Unfair Trade Practices

Zimbabwe's Competition and Tariff Commission has launched an investigation into Cimas Medical Aid, probing allegations of unfair trade practices. This official inquiry follows a complaint claiming Cimas limits patient choice and gives its own pharmacies an unfair market advantage.Supporters of the investigation argue it is vital to ensure fair competition and protect consumer rights within the critical healthcare sector. Cimas, implicitly, would counter that its operational model aims for efficiency and integrated care, not anti-competitive behavior, challenging the commission's interpretation of market dynamics.The Competition and Tariff Commission's probe directly targets Cimas's alleged advantage for its own pharmacies. The strategic shift for the healthcare market: Regulatory scrutiny threatens to reshape medical aid practices, potentially broadening patient choice but challenging established market players.